Atmospheric Glow Technologies, Inc. and AR Brown Co., Ltd. Announce Distribution Agreement.KNOXVILLE, Tenn. -- Atmospheric Glow Technologies, Inc. (AGT AGT antiglobulin test. ) (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : AGWT) and AR Brown Co., Ltd., Tokyo, Japan announce an agreement under which AR Brown Co., Ltd. will operate as the exclusive distributor of AGT's PlasmaGen APR-510-S in Japan. The PlasmaGen APR-510-S is a laboratory instrument that releases nucleic acid in less than two minutes from all classes of microorganisms including bacteria, bacterial endospores (e.g., anthrax), yeasts, fungi, and viruses. The release of nucleic acid is the first step towards detection, identification, and genetic characterization of microorganisms. The PlasmaGen APR-510-S uses a parallel set of electrodes, creating uniform plasma that ruptures microorganisms, releasing the DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. . The extracted DNA can then be used for further analysis with techniques such as electrophoresis or the polymerase chain reaction polymerase chain reaction (pŏl`ĭmərās') (PCR), laboratory process in which a particular DNA segment from a mixture of DNA chains is rapidly replicated, producing a large, readily analyzed sample of a piece of DNA; the process is (PCR PCR polymerase chain reaction. PCR abbr. polymerase chain reaction Polymerase chain reaction (PCR) ). AR Brown Co., Ltd. has an extensive background as a provider of goods and technical services to the biotechnology, chemical, pharmaceutical, automobile, and aerospace industries. "We believe it's very beneficial for AGT to have a presence in Japan, and to have our technologies further strengthened by AR Brown's reputation," stated AGT President and COO, Kim Wintenberg. "AR Brown can provide AGT access to top-quality Japanese scientists as potential end-users, and we're excited about the potential opportunities in this area." AGT is a publicly traded science and engineering company on the OTCBB (trading symbol AGWT), and offers an array of products based upon One Atmosphere Uniform Glow Discharge Plasma (OAUGDP OAUGDP One Atmosphere Uniform Glow Discharge Plasma (R)) technology. "Since coming on board this summer, I've been channeling AGT efforts to create additional strategic partnerships to facilitate commercialization efforts across our wide range of plasma-enabled technologies in addition to DNA preparation, including such areas as air purification, decontamination decontamination /de·con·tam·i·na·tion/ (de?kon-tam-i-na´shun) the freeing of a person or object of some contaminating substance, e.g., war gas, radioactive material, etc. de·con·tam·i·na·tion n. , sterilization, surface preparations and even treatments for fresh produce and other foodstuffs," said AGT CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Scott McDonald. Statements in this release that are not historical facts are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. In addition, words such as 'believes', 'anticipates', 'expects', and similar expressions are intended to identify forward looking statements. Such forward looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of events of the company, or events, or timing of events, relating to the company to differ materially from any future results, performance, or achievements of the forward-looking statements. The company cannot assure that it will be able to anticipate or respond timely to the changes, which could adversely affect its operating results in one or more fiscal quarters. Results of operations in any past period should not be considered indicative of results to be expected in future periods. Fluctuations in operating results may result in fluctuations in the price of the company's securities. |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion